Electrophilic androgen receptor (AR) antagonists for AR downregulation and ferroptosis induction in cancer cells
Abstract:
Isothiocyanate (ITC)-androgen receptor (AR) inhibitor conjugates for apoptosis induction in cancer cells are described. The conjugates can have electrophilicity blocked with an agent such as N-acetyl cysteine. When administered in combination with a glutathione (GSH)-depleting agent, the conjugates result in ferroptosis of cancer cells.
Information query
Patent Agency Ranking
0/0